Daniel J Drucker
@DanielJDrucker
A clinician scientist at LTRI @sinaihealth @uoft GLP-1, diabetes, obesity and the gut endocrine system Proud 🇨🇦Not going anywhere Am 🇮🇱Chai
ID:292334056
http://glucagon.com 03-05-2011 13:51:01
30,1K Tweets
29,0K Followers
1,1K Following
Follow People
Daniel J Drucker Molecular Metabolism Interesting.
However, Fasudil, a ROCK inhibitor is licensed in Japan for the treatment of vasospasms following subarachnoid hemorrhage since 1995. No signal of clinically relevant hyperglycemia in any of the studies. Activation of ROCK likely to worsen HTN, glaucoma, and IR.
Modest goals for #microbiota medicines “Monitoring and managing the intestinal microbiota may represent a next-generation medicine able to tackle or reduce the litany of chronic diseases and a pivotal component of personalized medicine” Trends in Microbiology cell.com/trends/microbi…
New #EndocrineReviews The molecular rationale for HIF2α blockade with a focus on neuroendocrine tumors academic.oup.com/edrv/advance-a…
The spatiotemporal landscape of lactate metabolism in health and disease Cell Metabolism cell.com/cell-metabolis…